Strong M&A may boost IPOs and private fundraisings.
Katherine Davis is a Biotech Deals Reporter at Axios. She covers a range of topics related to medicine and healthcare, including pharmaceutical manufacturing, regulation, and healthcare technology, while also delving into public health and patient care. Katherine's work has been featured in prominent publications such as Ad Age, Modern Healthcare, and BioSpace.













